Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2316.29	283.95	-11.75
Graham Fair Price	-90.39	0.74	7.69
PEG	-163879.21	-1.42	< 0.005
Price/Book	-18.98	0.97	1.20
Price/Cash Flow	-408.47	-712.90	-140.21
Prices/Earnings	8845.45	143.75	-1.61
Price/Sales	-11.89	23.18	26.31
Price/FCF	-408.47	-712.90	-140.21
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	120.41	0.27	-0.12
Operating Margin	-99.70	0.01	-4.73
ROA	-99.09	< 0.005	-0.16
ROE	-0.19	< 0.005	-99.09
ROIC	-0.19	< 0.005	-99.59
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.15	-0.08	80.28
Dividends QOQ	-0.04	-0.04	9.55
EBIT QOQ	-18.50	1.00	-94.58
EPS QOQ	-18.50	1.01	-94.54
FCF QOQ	0.22	0.84	280.28
Revenue QOQ	0.80	-0.08	-90.14
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-49.45	-82.37	-66.58
Days Sales Outstanding (DSO)	188.42	213.64	13.38
Inventory Turnover	-1.82	-1.09	39.97
Debt/Capitalization	0.04	0.05	14.07
Quick Ratio	1.45	1.45	0.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.75	3.79	0.93
Cash	0.33	0.33	-1.58
Capex	-0.01	< 0.005	61.40
Free Cash Flow	-0.03	< 0.005	83.92
Revenue	0.17	0.16	-7.18
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.89	1.85	-2.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.17	-2.40	1344.77
Naive Interpretation	Member

06 - Financial Health · Weak

Rating